Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-28

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved a supplemental application for fluvoxamine maleate by Apotex Corp. This approval confirms the continued availability of a generic version.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine (fluvoxamine)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)